Mutational Landscape in Hepatocellular Carcinoma
NCT03071458 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 808
Last updated 2025-12-10
Summary
The MUTHEC project aims to describe the mutational and transcriptomic landscape of HCC treated by curative treatments (resection, radio frequency ablation, transplantation) as well as advanced HCC together with the analysis of circulating tumor DNA.
Conditions
- HepatoCellular Carcinoma
- Cirrhosis
Sponsors & Collaborators
-
Institut National de la Santé Et de la Recherche Médicale, France
lead OTHER_GOV
Principal Investigators
-
jessica zucman-rossi, Md,Phd · Institut National de la Santé Et de la Recherche Médicale, France
-
jean-charles Nault · Assistance Publique - Hôpitaux de Paris
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2008-01-31
- Primary Completion
- 2015-05-31
- Completion
- 2015-05-31
Countries
- France
Study Locations
More Related Trials
-
A Study of MT-303 in Adults With Advanced or Metastatic GPC3-Expressing Cancers, Including HCC
NCT06478693 ·Status: RECRUITING ·Phase: PHASE1
-
Protein Biomarker in Hepatocellular Carcinoma
NCT00465842 ·Status: TERMINATED
-
Implication of Long Non-coding RNA HOTTIP Haplotype on Liver Cancer Metastasis
NCT06544005 ·Status: COMPLETED
-
The Efficacy and Safety of EOB-MRI Guided Microwave Ablation for Early HCC: A Multicenter, Prospective, Observational Study
NCT06096896 ·Status: ACTIVE_NOT_RECRUITING
-
Single Centre Prospective Evaluation of 68Gallium-FAPI PET/MRI in Hepatocellular Carcinoma
NCT05687747 ·Status: RECRUITING ·Phase: PHASE1
-
Myeloid Derived Suppressor Cells Control by Signal Regulatory Protein-alpha: Investigation in Hepatocellular Carcinoma
NCT02868255 ·Status: COMPLETED
-
The Value of 68Ga-FAPI PET/CT in the Efficacy Evaluation of Advanced Unresectable Hepatocellular Carcinoma Patients Undergoing Systemic Antitumor Therapy
NCT06746194 ·Status: RECRUITING
-
Multi-center Study on Therapy-oriented Molecular Subtyping of Hepatocellular Carcinoma
NCT03668158 ·Status: UNKNOWN
-
Application of mRNA Vaccine in Liver Transplantation for Hepatocellular Carcinoma
NCT07077356 ·Status: RECRUITING ·Phase: PHASE1
-
Ambispective Cohort Study of Precision Medicine for Primary Hepatobiliary Cancer Based on Next-generation Sequencing
NCT05520788 ·Status: RECRUITING
-
Study to Evaluate the Safety and Effectiveness of Microwave Ablation in Patients With Hepatocellular Carcinoma in Korea
NCT03586050 ·Status: COMPLETED ·Phase: NA
-
A Study of Molecular and Genetic Factors for Liver Cancer in the Greater Baltimore Area
NCT00913757 ·Status: COMPLETED
-
Application of Integrated Proteomic and Serum Metabolomic Analysis in Assessing the Efficacy and Prognosis of TACE Combined With Targeted Immunotherapy in Unresectable Hepatocellular Carcinoma
NCT06540508 ·Status: ENROLLING_BY_INVITATION
-
Sequential Treatment of Hepatocellular Carcinoma by Transarterial Chemoembolization and Local Ablation or External Radiation
NCT04813861 ·Status: COMPLETED
-
Hepatocellular Carcinoma 3 Gene Methylation Combination Detection Kit (PCR Fluorescent Probe Method) Multicenter Clinical Trial
NCT06842563 ·Status: ACTIVE_NOT_RECRUITING
-
Molecular Basis of Pediatric Liver Cancer
NCT03959800 ·Status: RECRUITING
-
A Study of Chromosomal Abnormalities as a Predictor of Staging and Prognosis in Patients With Liver Cancer
NCT05371873 ·Status: UNKNOWN
-
Safety and Efficacy Evaluation of MUC-1 CART in the Treatment of Intrahepatic Cholangiocarcinoma
NCT03633773 ·Status: UNKNOWN ·Phase: PHASE1/PHASE2
-
Deep, Multi-omics Phenotyping to Predict Response, Resistance and Recurrence to Adjuvant Atezolizumab Plus Bevacizumab in Resected Hepatocellular Carcinoma
NCT05516628 ·Status: RECRUITING ·Phase: PHASE2
-
Cohort of Patients With Hepatocellular Carcinoma or Cholangiocarcinoma
NCT04340986 ·Status: RECRUITING
-
Rg3 in Combination With TACE in Hepatocellular Carcinoma Patients With High Expression of Notch1
NCT02724358 ·Status: COMPLETED ·Phase: NA
-
Prospective Collection of Therapeutic Efficacy and Safety Data in Patients with Unresectable Hepatocellular Carcinoma
NCT06788353 ·Status: RECRUITING
-
TACE, Sorafenib and PD-1 Monoclonal Antibody in the Treatment of HCC
NCT04518852 ·Status: COMPLETED ·Phase: PHASE2
-
Characterization of Methylation Patterns in Hepatocellular Carcinoma
NCT04264754 ·Status: TERMINATED
-
Stereotactic Body Radiation Therapy for Hepatocellular Carcinoma
NCT01850667 ·Status: COMPLETED ·Phase: PHASE2